Please login to the form below

Not currently logged in
Email:
Password:

Sigma-Tau Pharmaceuticals appoints Dave Lemus chief operating officer

He takes over from Gregg Lapointe who has resigned

Dave Lemus has been appointed chief operating officer at Sigma-Tau Pharmaceuticals.

He joined the US rare diseases company in July 2011 as VP, finance and in his new role he takes over from Gregg Lapointe who has resigned.

President of Sigma-Tau Pharmaceuticals Professor Trevor Jones said: "We are delighted to appoint Dave to lead our efforts to expand the world-class rare disease business we have established in the US.

“Dave brings a wealth of relevant pharmaceutical and biotech experience from both the US and Europe. His appointment will serve to further strengthen our unwavering mission to serve the needs of rare disease patients."

Prior to joining Sigma-Tau Lemus was chief financial officer at German biotech company MorphoSys, where he launched Germany's first-ever biotechnology IPO in 1999.

Before this he held a variety of senior management roles at Hoffmann-La Roche and Lindt in Switzerland.

12th March 2012

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Aptus Health

Aptus Health is dedicated to advancing health engagement. The company offers end-to-end digital health engagement solutions spanning all areas of...

Latest intelligence

What pharma marketers can learn from behavioural science
Pharma behavioural science and traditional emotional marketing create a powerful mix of techniques that have impact on real lives....
NEW EU DATA PROTECTION REGULATION POISED TO CHANGE DATA PRIVACY LANDSCAPE
NEW EU DATA PROTECTION REGULATION POISED TO CHANGE DATA PRIVACY LANDSCAPE The bold digital clock featured on the EUGDPR (EU General Data Protection Regulation)1 website indicates – to the second...
Health knowledge: Why is it so important?
Health knowledge plays an important role in population health, but by itself is rarely enough to prompt a change in the behaviours that cause the risks....

Infographics